ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis

Zhao, Hai Lan; Chen, Shu Zhen; Xu, Hao Ming; Zhou, You Lian; He, Jie; Huang, Hong Li; Xu, Jing; Nie, Yu Qiang*1
Journal of Digestive Diseases2020-10DOI: 10.1111/1751-2980.12933
19被引4阅读
引用收藏
分享

摘要

Objectives To assess the effect of donor selection, stool procedures and pretreatment with antibiotics on the efficacy and safety of fecal microbiota transplantation (FMT)-treated ulcerative colitis (UC). Methods A systematic review and meta-analysis was conducted including studies on UC treated with FMT as the primary therapeutic agent published up to June 30, 2020. Primary end-point data included clinical remission (CR) or CR combined with endoscopic remission. Results A total of 37 studies (seven random controlled trials [RCTs], five controlled and 25 uncontrolled cohort studies) and 959 patients with UC were enrolled. In controlled cohort studies and RCTs, FMT had a significantly greater benefit than placebo (pooled odds ratio [P-OR] 3.392, 95% CI 2.196-5.240,P < 0.001), with no heterogeneity (I-2= 0%). Furthermore, administration of FMT via the lower gastrointestinal (GI) tract was more effective in achieving CR than via the upper GI tract (44.3% vs 31.7%). The remission rate was also higher when the total stool dosage was over 275 g compared with less than 275 g (51.9% vs 29.5%). Overall, the incidence of serious adverse events of FMT was 5.9%. There was no significant difference between single and multiple donors, fresh and frozen stool sample used, and whether or not antibiotic pretreatment was administered before FMT. Conclusion FMT administration via the lower GI tract and using higher dosage appear to be effective and safe in inducing remission of active UC.

学科与关键词

关键词
donor selectionfecal microbiota transplantationfecal microbiota transplantation deliverypretreatment with antibioticulcerative colitis
相关
加载中…
  • Fecal microbiota transplantation ameliorates active ulcerative colitis
    Chen, Hui-Ting; Huang, Hong-Li; Xu, Hao-Ming; Luo, Qing-Ling; He, Jie; Li, Yong-Qiang; Zhou, You-Lian; Nie, Yu-Qiang*; Zhou, Yong-Jian*Experimental and Therapeutic Medicine, 2020, 19(4): 2650-2660.被引 31
  • Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation
    Xu, Hao-Ming; Huang, Hong-Li; Xu, Jing; He, Jie; Zhao, Chong; Peng, Yao; Zhao, Hai-Lan; Huang, Wen-Qi; Cao, Chuang-Yu; Zhou, Yong-Jian; Zhou, You-Lian*; Nie, Yu-Qiang*Frontiers in Microbiology, 2021, 12: 658292.被引 28
  • Fecal microbiota transplantation improves intestinal inflammation in mice with ulcerative colitis by modulating intestinal flora composition and down-regulating NF-kB signaling pathway
    Li, Dongyue; Cui, Lanrong; Gao, Yanhong; Li, Yang; Tan, Xin; Xu, Hongyu*Microbial Pathogenesis, 2022, 173: 105803.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Digestive Diseases
发表日期
2020-10
卷期
第 21 卷, 第 10 期
页码
534-548
DOI
10.1111/1751-2980.12933
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhao, Hai Lan (第一作者)

    1

  • C

    Chen, Shu Zhen

    1

查看全部 8 位作者收起作者
  • X

    Xu, Hao Ming

    1

  • Z

    Zhou, You Lian

    1

  • H

    He, Jie

    1

  • H

    Huang, Hong Li

    1

  • X

    Xu, Jing

    1

  • N

    Nie, Yu Qiang (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417